feed,title,long_url,short_url
Benzinga,Mid-Cap Firm Annexon's Nerve Disorder Candidate Shows Promise In Pivotal Late-Stage Study,https://benzinga.com/general/biotech/24/06/39165249/mid-cap-firm-annexons-nerve-disorder-candidate-shows-promise-in-pivotal-late-stage-study,https://da.gd/P2QJay
